14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for UN9.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.33 0.644 %
R2 8.30 0.275 %
R1 8.28 0.0470 %
Current price: 8.28
Support S1 8.22 -0.691 %
S2 8.20 -0.92 %
S3 8.17 -1.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.31 0.362 %
R2 8.30 0.242 %
R1 8.29 0.121 %
Current price 8.28
Support S1 8.19 -1.09%
S2 8.08 -2.42%
S3 7.90 -4.59%

UN9.F Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About UNIQA Insurance Group AG

UNIQA Insurance Group AG Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... UN9.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT